Ind., said that a forthcoming report will outline proposed requirements that “reimagine” the U.S. biotechnology R&D landscape ...

The U.S. is falling behind in biotechnology development, Sen. Todd Young, R-Ind., said Wednesday—adding that he and other ...

The expiration of the SBIR program comes as New York’s burgeoning life sciences market races to catch up to major biotech hubs across the country. The city has long lagged behind cities including ...

Robert Langer, a hugely influential biotech innovator, expects the industry will get through its latest slowdown. He's more ...

The groundbreaking immunology research behind two Nobel Prizes awarded this week traces back to a largely forgotten biotech ...

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

BIOSPAIN showed how partnering conferences connect public funding, venture capital, and pharma to drive biotech innovation to ...

Centuries before biotechnology had a name, humans were already practicing it – breeding animals for resilience, fermenting foods and treating pain with plants. Today, that same spirit of discovery ...

ATLANTA, March 25, 2025 /PRNewswire/ -- Truist Securities announced today that Danielle Brill has joined the firm as managing director, strengthening its equity research coverage in the biotechnology ...

Vir Biotechnology, Inc. (VIR) shares soared 6.9% in the last trading session to close at $6.05. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...